Loading...

Skip to main content

Call us on + 1 (800) 604-9114 for more information about our products

Looking for specific datasheet Manual/COA/MSDS?
Request a Manual/COA/MSDS

Interested to get a quote about our products?
Request a Quote

SDS-PAGE

Tyrosinase Recombinant Protein | TYR recombinant protein

Recombinant Human Tyrosinase, partial

Gene Names
TYR; ATN; CMM8; OCA1; OCA1A; OCAIA; SHEP3
Purity
Greater or equal to 85% purity as determined by SDS-PAGE.
Synonyms
Tyrosinase; Recombinant Human Tyrosinase; partial; LB24-AB; Monophenol monooxygenase; SK29-AB; Tumor rejection antigen AB; TYR recombinant protein
Ordering
For Research Use Only!
Host
E Coli or Yeast or Baculovirus or Mammalian Cell
Purity/Purification
Greater or equal to 85% purity as determined by SDS-PAGE.
Form/Format
Lyophilized or liquid (Format to be determined during the manufacturing process)
Sequence Positions
19-377. Partial
Sequence
HFPRACVSSKNLMEKECCPPWSGDRSPCGQLSGRGSCQNILLSNAPLGPQFPFTGVDDRESWPSVFYNRTCQCSGNFMGFNCGNCKFGFWGPNCTERRLLVRRNIFDLSAPEKDKFFAYLTLAKHTISSDYVIPIGTYGQMKNGSTPMFNDINIYDLFVWMHYYVSMDALLGGSEIWRDIDFAHEAPAFLPWHRLFLLRWEQEIQKLTGDENFTIPYWDWRDAEKCDICTDEYMGGQHPTNPNLLSPASFFSSWQIVCSRLEEYNSHQSLCNGTPEGPLRRNPGNHDKSRTPRLPSSADVEFCLSLTQYESGSMDKAANFSFRNTLEGFASPLTGIADASQSSMHNALHIYMNGTMSQV
Preparation and Storage
Store at -20 degree C, for extended storage, conserve at -20 degree C or -80 degree C.

SDS-PAGE

SDS-PAGE
Related Product Information for TYR recombinant protein
This is a copper-containing oxidase that functions in the formation of pigments such as melanins and other polyphenolic compounds. Catalyzes the rate-limiting conversions of tyrosine to DOPA, DOPA to DOPA-quinone and possibly 5,6-dihydroxyindole to indole-5,6 quinone.
Product Categories/Family for TYR recombinant protein
References
Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment.Giebel L.B., Strunk K.M., Spritz R.A.Genomics 9:435-445(1991) Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus.Kwon B.S., Haq A.K., Pomerantz S.H., Halaban R.Proc. Natl. Acad. Sci. U.S.A. 84:7473-7477(1987) ErratumKwon B.S., Haq A.K., Pomerantz S.H., Halaban R.Proc. Natl. Acad. Sci. U.S.A. 85:6352-6352(1988) Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA.Bouchard B., Fuller B.B., Vijayasaradhi S., Houghton A.N.J. Exp. Med. 169:2029-2042(1989) A single base insertion in the putative transmembrane domain of the tyrosinase gene as a cause for tyrosinase-negative oculocutaneous albinism.Chintamaneni C.D., Halaban R., Kobayashi Y., Witkop C.J., Kwon B.S.Proc. Natl. Acad. Sci. U.S.A. 88:5272-5276(1991) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.Brichard V., van Pel A., Woelfel T., Woelfel C., de Plaen E., Lethe B.G., Coulie P., Boon T.J. Exp. Med. 178:489-495(1993) The tyrosinase gene in gorillas and the albinism of 'Snowflake'.Martinez-Arias R., Comas D., Andres A., Abello M.-T., Domingo-Roura X., Bertranpetit J.Pigment Cell Res. 13:467-470(2000) Characteristic sequences in the upstream region of the human tyrosinase gene.Kikuchi H., Miura H., Yamamoto H., Takeuchi T., Dei T., Watanabe M.Biochim. Biophys. Acta 1009:283-286(1989) Functional analysis of the cDNA encoding human tyrosinase precursor.Takeda A., Tomita Y., Okinaga S., Tagami H., Shibahara S.Biochem. Biophys. Res. Commun. 162:984-990(1989) Molecular phylogenetics and the origins of placental mammals.Murphy W.J., Eizirik E., Johnson W.E., Zhang Y.-P., Ryder O.A., O'Brien S.J.Nature 409:614-618(2001) Molecular basis of type I (tyrosinase-related) oculocutaneous albinism mutations and polymorphisms of the human tyrosinase gene.Oetting W.S., King R.A.Hum. Mutat. 2:1-6(1993) Molecular basis of albinism mutations and polymorphisms of pigmentation genes associated with albinism.Oetting W.S., King R.A.3.3.CO;2-3>Hum. Mutat. 13:99-115(1999) Proteomic analysis of early melanosomes identification of novel melanosomal proteins.Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K., Valencia J., Muller J., Vieira W.D., Watabe H., Shabanowitz J., Hearing V.J., Hunt D.F., Appella E.J. Proteome Res. 2:69-79(2003) Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.J. Proteome Res. 5:3135-3144(2006) Detection of mutations in the tyrosinase gene in a patient with type IA oculocutaneous albinism.Spritz R.A., Strunk K.M., Giebel L.B., King R.A.N. Engl. J. Med. 322:1724-1728(1990) A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism.Giebel L.B., Strunk K.M., King R.A., Hanifin J.M., Spritz R.A.Proc. Natl. Acad. Sci. U.S.A. 87:3255-3258(1990) Tyrosinase gene mutations associated with type IB ('yellow') oculocutaneous albinism.Giebel L.B., Tripathi R.K., Strunk K.M., Hanifin J.M., Jackson C.E., King R.A., Spritz R.A.Am. J. Hum. Genet. 48:1159-1167(1991) ErratumGiebel L.B., Tripathi R.K., Strunk K.M., Hanifin J.M., Jackson C.E., King R.A., Spritz R.A.Am. J. Hum. Genet. 49:696-696(1991) Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.Tripathi R.K., Strunk K.M., Giebel L.B., Weleber R.G., Spritz R.A.Am. J. Med. Genet. 43:865-871(1992) Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism.Spritz R.A., Strunk K.M., Hsieh C.-L., Sekhon G.S., Francke U.Am. J. Hum. Genet. 48:318-324(1991) A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.Giebel L.B., Tripathi R.K., King R.A., Spritz R.A.J. Clin. Invest. 87:1119-1122(1991) Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.King R.A., Mentink M.M., Oetting W.S.Mol. Biol. Med. 8:19-29(1991) Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.Oetting W.S., King R.A.Hum. Genet. 90:258-262(1992) Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA) .Tripathi R.K., Bundey S., Musarella M.A., Droetto S., Strunk K.M., Holmes S.A., Spritz R.A.Am. J. Hum. Genet. 53:1173-1179(1993) Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.Gershoni-Baruch R., Rosenmann A., Droetto S., Holmes S.A., Tripathi R.K., Spritz R.A.Am. J. Hum. Genet. 54:586-594(1994) Initiation codon mutation of the tyrosinase gene as a cause of human albinism.Breimer L.H., Winder A.F., Jay B., Jay M.Clin. Chim. Acta 227:17-22(1994) Diagnosis of oculocutaneous albinism with molecular analysis.Summers C.G., Oetting W.S., King R.A.Am. J. Ophthalmol. 121:724-726(1996) Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA) .Morell R., Spritz R.A., Ho L., Pierpont J., Guo W., Friedman T.B., Asher J.H. Jr.Hum. Mol. Genet. 6:659-664(1997) Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1) .Spritz R.A., Oh J., Fukai K., Holmes S.A., Ho L., Chitayat D., France T.D., Musarella M.A., Orlow S.J., Schnur R.E., Weleber R.G., Levin A.V.3.0.CO;2-X>Hum. Mutat. 10:171-174(1997) Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1) .Oetting W.S., Fryer J.P., King R.A.3.3.CO;2-7>Hum. Mutat. 12:433-434(1998) ErratumOetting W.S., Fryer J.P., King R.A.Hum. Mutat. 13:83-83(1999) Novel and recurrent mutations in the tyrosinase gene and the P gene in the German albino population.Passmore L.A., Kaesmann-Kellner B., Weber B.H.F.Hum. Genet. 105:200-210(1999) ErratumPassmore L.A., Kaesmann-Kellner B., Weber B.H.F.Hum. Genet. 108:208-208(2001) Insertion/deletion mutations of type I oculocutaneous albinism in Chinese patients from Taiwan.Tsai C.-H., Tsai F.-J., Wu J.-Y., Lin S.-P., Chang J.-G., Yang C.-F., Lee C.-C.3.0.CO;2-3>Hum. Mutat. 14:542-542(1999) Mutation analysis of the tyrosinase gene in oculocutaneous albinism.Camand O., Marchant D., Boutboul S., Pequignot M., Odent S., Dollfus H., Sutherland J., Levin A., Menasche M., Marsac C., Dufier J.-L., Heon E., Abitbol M.Hum. Mutat. 17:352-352(2001) A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1) .Nakamura E., Miyamura Y., Matsunaga J., Kano Y., Dakeishi-Hara M., Tanita M., Kono M., Tomita Y.J. Dermatol. Sci. 28:102-105(2002) Detection of 53 novel DNA variations within the tyrosinase gene and accumulation of mutations in 17 patients with albinism.Opitz S., Kaesmann-Kellner B., Kaufmann M., Schwinger E., Zuehlke C.Hum. Mutat. 23:630-631(2004) A genomewide association study of skin pigmentation in a South Asian population.Stokowski R.P., Pant P.V.K., Dadd T., Fereday A., Hinds D.A., Jarman C., Filsell W., Ginger R.S., Green M.R., van der Ouderaa F.J., Cox D.R.Am. J. Hum. Genet. 81:1119-1132(2007) Genetic determinants of hair, eye and skin pigmentation in Europeans.Sulem P., Gudbjartsson D.F., Stacey S.N., Helgason A., Rafnar T., Magnusson K.P., Manolescu A., Karason A., Palsson A., Thorleifsson G., Jakobsdottir M., Steinberg S., Palsson S., Jonasson F., Sigurgeirsson B., Thorisdottir K., Ragnarsson R., Benediktsdottir K.R., Aben K.K., Kiemeney L.A., Olafsson J.H., Gulcher J., Kong A., Thorsteinsdottir U., Stefansson K.Nat. Genet. 39:1443-1452(2007) A population-based study of autosomal-recessive disease-causing mutations in a founder population.Chong J.X., Ouwenga R., Anderson R.L., Waggoner D.J., Ober C.Am. J. Hum. Genet. 91:608-620(2012) DNA variations in oculocutaneous albinism an updated mutation list and current outstanding issues in molecular diagnostics.Simeonov D.R., Wang X., Wang C., Sergeev Y., Dolinska M., Bower M., Fischer R., Winer D., Dubrovsky G., Balog J.Z., Huizing M., Hart R., Zein W.M., Gahl W.A., Brooks B.P., Adams D.R.Hum. Mutat. 34:827-835(2013) Identification of a novel mutation (p.Ile198Thr) in gene TYR in a Pakistani family with nonsyndromic oculocutaneous albinism.Shah S.A., Din S.U., Raheem N., Daud S., Mubeen J., Nadeem A., Tayyab M., Baloch D.M., Babar M.E., Ahmad J.Clin. Exp. Dermatol. 39:646-648(2014) +Additional computationally mapped references.<p>Provides general information on the entry.

NCBI and Uniprot Product Information

NCBI GI #
NCBI GeneID
NCBI Accession #
NCBI GenBank Nucleotide #
UniProt Accession #
Molecular Weight
42.7 kDa
NCBI Official Full Name
tyrosinase
NCBI Official Synonym Full Names
tyrosinase
NCBI Official Symbol
TYR
NCBI Official Synonym Symbols
ATN; CMM8; OCA1; OCA1A; OCAIA; SHEP3
NCBI Protein Information
tyrosinase
UniProt Protein Name
Tyrosinase
Protein Family
UniProt Gene Name
TYR
UniProt Entry Name
TYRO_HUMAN

NCBI Description

The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene. [provided by RefSeq, Oct 2008]

Uniprot Description

TYR: This is a copper-containing oxidase that functions in the formation of pigments such as melanins and other polyphenolic compounds. Catalyzes the rate-limiting conversions of tyrosine to DOPA, DOPA to DOPA-quinone and possibly 5,6-dihydroxyindole to indole-5,6 quinone. Increased expression after UVB irradiation. Belongs to the tyrosinase family. 2 isoforms of the human protein are produced by alternative splicing.

Protein type: Oxidoreductase; EC 1.14.18.1; Membrane protein, integral; Cofactor and Vitamin Metabolism - riboflavin; Amino Acid Metabolism - tyrosine

Chromosomal Location of Human Ortholog: 11q14.3

Cellular Component: cytoplasm; cytosol; Golgi-associated vesicle; integral to membrane; lysosome; melanosome; melanosome membrane; nucleus; perinuclear region of cytoplasm

Molecular Function: copper ion binding; monooxygenase activity; monophenol monooxygenase activity; protein binding; protein heterodimerization activity; protein homodimerization activity

Biological Process: cell proliferation; eye pigment biosynthetic process; melanin biosynthetic process; melanin biosynthetic process from tyrosine; response to cAMP; response to UV; response to vitamin D; thymus development; visual perception

Disease: Albinism, Ocular, With Sensorineural Deafness; Albinism, Oculocutaneous, Type Ia; Albinism, Oculocutaneous, Type Ib; Skin/hair/eye Pigmentation, Variation In, 3

Research Articles on TYR

Similar Products

Product Notes

The TYR tyr (Catalog #AAA951131) is a Recombinant Protein produced from E Coli or Yeast or Baculovirus or Mammalian Cell and is intended for research purposes only. The product is available for immediate purchase. The immunogen sequence is 19-377. Partial. The amino acid sequence is listed below: HFPRACVSSK NLMEKECCPP WSGDRSPCGQ LSGRGSCQNI LLSNAPLGPQ FPFTGVDDRE SWPSVFYNRT CQCSGNFMGF NCGNCKFGFW GPNCTERRLL VRRNIFDLSA PEKDKFFAYL TLAKHTISSD YVIPIGTYGQ MKNGSTPMFN DINIYDLFVW MHYYVSMDAL LGGSEIWRDI DFAHEAPAFL PWHRLFLLRW EQEIQKLTGD ENFTIPYWDW RDAEKCDICT DEYMGGQHPT NPNLLSPASF FSSWQIVCSR LEEYNSHQSL CNGTPEGPLR RNPGNHDKSR TPRLPSSADV EFCLSLTQYE SGSMDKAANF SFRNTLEGFA SPLTGIADAS QSSMHNALHI YMNGTMSQV . It is sometimes possible for the material contained within the vial of "Tyrosinase, Recombinant Protein" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.

Precautions

All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.

Disclaimer

Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.

Item has been added to Shopping Cart

If you are ready to order, navigate to Shopping Cart and get ready to checkout.

Looking for a specific manual?
Request a Manual

Request more Information

Please complete the form below and a representative will contact you as soon as possible.

Request a Manual

Please complete the form below and a representative will contact you as soon as possible.

Request a Quote

Please complete the form below and a representative will contact you as soon as possible.